Literature DB >> 26540494

Anti-HIV-1 activity of a tripodal receptor that recognizes mannose oligomers.

Eva Rivero-Buceta1, Paula Carrero2, Elena Casanova3, Elisa G Doyagüez4, Andrés Madrona1, Ernesto Quesada1, María Jesús Peréz-Pérez1, Raquel Mateos5, Laura Bravo5, Leen Mathys6, Sam Noppen6, Evgeny Kiselev7, Christophe Marchand7, Yves Pommier7, Sandra Liekens6, Jan Balzarini6, María José Camarasa1, Ana San-Félix8.   

Abstract

The glycoprotein gp120 of the HIV-1 viral envelope has a high content in mannose residues, particularly α-1,2-mannose oligomers. Compounds that interact with these high-mannose type glycans may disturb the interaction between gp120 and its (co)receptors and are considered potential anti-HIV agents. Previously, we demonstrated that a tripodal receptor (1), with a central scaffold of 1,3,5-triethylbenzene substituted with three 2,3,4-trihydroxybenzoyl groups, selectively recognizes α-1,2-mannose polysaccharides. Here we present additional studies to determine the anti-HIV-1 activity and the mechanism of antiviral activity of this compound. Our studies indicate that 1 shows anti-HIV-1 activity in the low micromolar range and has pronounced gp120 binding and HIV-1 integrase inhibitory capacity. However, gp120 binding rather than integrase inhibition seems to be the primary mechanism of antiviral activity of 1.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  AIDS; Antiviral agents; HIV; Integrase; Polyphenols

Mesh:

Substances:

Year:  2015        PMID: 26540494      PMCID: PMC7750885          DOI: 10.1016/j.ejmech.2015.10.027

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  18 in total

Review 1.  Host cell glycosylation of viral glycoproteins--a battlefield for host defence and viral resistance.

Authors:  S Olofsson; J E Hansen
Journal:  Scand J Infect Dis       Date:  1998

2.  Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV.

Authors:  Jan Balzarini
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

Review 3.  HIV drug development: the next 25 years.

Authors:  Charles Flexner
Journal:  Nat Rev Drug Discov       Date:  2007-12       Impact factor: 84.694

4.  Rational design of a fluorescence-turn-on sensor array for phosphates in blood serum.

Authors:  Grigory V Zyryanov; Manuel A Palacios; Pavel Anzenbacher
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

5.  Antioxidant activity of hydroxytyrosol acetate compared with that of other olive oil polyphenols.

Authors:  M H Gordon; F Paiva-Martins; M Almeida
Journal:  J Agric Food Chem       Date:  2001-05       Impact factor: 5.279

Review 6.  Antiretroviral therapy and management of HIV infection.

Authors:  Paul A Volberding; Steven G Deeks
Journal:  Lancet       Date:  2010-07-03       Impact factor: 79.321

7.  Highly effective acyclic carbohydrate receptors consisting of aminopyridine, imidazole, and indole recognition units.

Authors:  Monika Mazik; Matthias Kuschel
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

8.  Synthesis and HIV-1 inhibitory activities of dicaffeoyl and digalloyl esters of quinic acid derivatives.

Authors:  C O R Junior; S C Verde; C A M Rezende; W Caneschi; M R C Couri; B R McDougall; W E Robinson; M V de Almeida
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

9.  Highly effective receptors showing di- vs. monosaccharide preference.

Authors:  Monika Mazik; Arno C Buthe
Journal:  Org Biomol Chem       Date:  2008-03-14       Impact factor: 3.876

10.  Mannose glycoconjugates functionalized at positions 1 and 6. Binding analysis to DC-SIGN using biosensors.

Authors:  José J Reina; Olivia S Maldonado; Georges Tabarani; Franck Fieschi; Javier Rojo
Journal:  Bioconjug Chem       Date:  2007-03-10       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.